We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
ACD/Labs Announces an Important Investment by Sanofi-Aventis for Production Facilities in Europe
News

ACD/Labs Announces an Important Investment by Sanofi-Aventis for Production Facilities in Europe

ACD/Labs Announces an Important Investment by Sanofi-Aventis for Production Facilities in Europe
News

ACD/Labs Announces an Important Investment by Sanofi-Aventis for Production Facilities in Europe

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "ACD/Labs Announces an Important Investment by Sanofi-Aventis for Production Facilities in Europe"

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Advanced Chemistry Development, Inc., (ACD/Labs) recently sold a suite of NMR software to Sanofi-Aventis, for use by five of its Process Development teams in production facilities in France, Germany, and Hungary.

NMR analysis is used in drug manufacturing to help identify impurities and degradants during filing and scale-up production process, and can also be used in a quality assurance capacity to help monitor the composition of the finished product.

Sanofi-Aventis needed a solution that would allow the analytical groups at some of its European Process Development sites to support internal clients with NMR analysis. ACD/1D and 2D NMR Managers allow for off-instrument processing of analytical data and the ability to store results in a database searchable by structure as well as other parameters.

ACD/Labs’ NMR Predictors provide predictions of 1D (1H, 13C, 15N, 19F, and 31P) and 2D NMR spectra, to help in the rapid interpretation and identification of potential impurities and degradants.

“With the help of ACD/Labs software tools we expect to be able to provide results to our internal clients, more quickly and accurately than in the past,” said Philippe Cleon, Head of Structural Analysis in Process Development (Neuville, France). “We were impressed with the ease of use of the software as well as the accuracy of the results we were able to obtain with these tools.”

“Before and during the implementation process, Sanofi-Aventis will receive full technical support from our staff.” said Yves Lorrain, Director of Sales, Chemcad. Chemcad is the distributor of ACD/Labs products for parts of Western Europe, including France, Belgium, Spain, The Netherlands, Sweden, Norway, Finland, and Denmark.

Advertisement